OPTIMIZING CALCINEURIN INHIBITOR EXPOSURE IN KIDNEY TRANSPLANT RECIPIENTS EARLY AFTER TRANSPLANTATION

被引：0
|
作者：
Press, R. R. [1 ]
Ploeger, B. A. [2 ]
den Hartigh, J. [1 ]
van der Straaten, T. [1 ]
van Pelt, H. [1 ]
Danhof, M. [2 ]
de Fijter, H. [1 ]
Guchelaar, H. [1 ]
机构：
[1] Leiden Univ, Med Ctr, Leiden, Netherlands
[2] LACDR, LAPP, Leiden, Netherlands
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2009年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S38 / S38
页数：1
相关论文
共 50 条
  • [21] Calcineurin inhibitor minimisation versus continuation of calcineurin inhibitor treatment for liver transplant recipients
    Penninga, Luit
    Wettergren, Andre
    Chan, An-Wen
    Steinbuechel, Daniel A.
    Gluud, Christian
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (03):
  • [22] Early and recurrent hospitalization after kidney transplantation: Analysis of a contemporary canadian cohort of kidney transplant recipients
    Bergman, Joel
    Tennankore, Karthik
    Vinson, Amanda
    [J]. CLINICAL TRANSPLANTATION, 2020, 34 (08)
  • [23] Calcineurin inhibitor-free immunosuppressive regimen for marginal donors/recipients of kidney transplantation
    Donati, D
    Ambrosini, A
    Marconi, A
    Mazzola, E
    [J]. TRANSPLANTATION PROCEEDINGS, 2002, 34 (05) : 1678 - 1680
  • [24] Impact of Sirolimus versus Mycophenolate Mofetil on Kidney Function after Calcineurin Inhibitor Dose Reduction in Liver Transplant Recipients
    Chiang, Heng-Yi
    Li, Lung-Chih
    Hsu, Chien-Ning
    Lin, Chih-Che
    Chan, Yi-Chia
    Wang, Chih-Chi
    Chen, Chao-Long
    [J]. PHARMACEUTICALS, 2023, 16 (08)
  • [25] Everolimus Plus Reduced-Exposure Calcineurin Inhibitor Versus Mycophenolate Mofetil Plus Standard-Exposure Calcineurin Inhibitor: 2-Year Results in Living Donor Kidney Transplant Recipients
    Watarai, Y.
    Akutsu, N.
    Saito, K.
    Nakagawa, Y.
    Kamisawa, O.
    Kenmochi, T.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [26] Echocardiographic Changes in Nondiabetic Kidney Transplant Recipients after Conversion from a Calcineurin Inhibitor to an Anti-mTOR Drug
    Ruiz-Esteban, P.
    Gaitan, D.
    Lopez, V.
    Maxuecos, A.
    Burgos, D.
    Collantes, R.
    Briceno, E.
    De Mora, M.
    Hernandez, D.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 35 - 35
  • [27] Calcineurin inhibitor minimization, withdrawal and avoidance protocols after kidney transplantation
    Haller, Maria
    Oberbauer, Rainer
    [J]. TRANSPLANT INTERNATIONAL, 2009, 22 (01) : 69 - 77
  • [28] Everolimus Initiation and Early Calcineurin Inhibitor Withdrawal in Heart Transplant Recipients: A Randomized Trial
    Andreassen, A. K.
    Andersson, B.
    Gustafsson, F.
    Eiskjaer, H.
    Rdegran, G.
    Gude, E.
    Jansson, K.
    Solbu, D.
    Sigurdardottir, V.
    Arora, S.
    Dellgren, G.
    Gullestad, L.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 (08) : 1828 - 1838
  • [29] Calcineurin (CNI) Exposure Reduces the Risk of Post-Transplant DSA After Deceased Donor Kidney Transplantation
    Pelletier, R.
    Rajab, A.
    Bumgardner, G.
    Henry, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [30] SHOULD KIDNEY TRANSPLANT RECIPIENTS RECEIVE CHILDREN AFTER TRANSPLANTATION?
    van Buren, Marleen
    Rischen-Vos, Jaqueline
    Roodnat, Joke
    Tielen, Mirjam
    Kal, Judith
    Weimar, Willem
    [J]. TRANSPLANT INTERNATIONAL, 2011, 24 : 131 - 131
12345